Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88BP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,794
Award facts
- Contract value 100% obligated
- $18,793.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $18,793.80 and an ultimate completion date of November 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical vendor supporting the Defense Health Agency and military healthcare systems. As a major pharmaceutical distributor, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains through the DLA Medical Supply Chain. The Ozempic diabetes medication procurement supports ongoing pharmaceutical needs for military personnel and beneficiaries. AmerisourceBergen's federal contract performance history demonstrates consistent capability to meet competitive procurement requirements through its comprehensive prime vendor contract vehicle, which enables flexible global pharmaceutical support across diverse healthcare commodities and customer bases within the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F88BP?
SPE2DR26F88BP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F88BP worth?
The government has obligated $18,794 on SPE2DR26F88BP.
Is contract SPE2DR26F88BP an order under another contract?
Yes. SPE2DR26F88BP is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88BP competed?
The extent of competition for SPE2DR26F88BP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award